Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP448884.RAOCoA1zHTAflEzGqGLbpgyhruY19Ztlm7YJ_ZPdbeiL8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP448884.RAOCoA1zHTAflEzGqGLbpgyhruY19Ztlm7YJ_ZPdbeiL8130_assertion type Assertion NP448884.RAOCoA1zHTAflEzGqGLbpgyhruY19Ztlm7YJ_ZPdbeiL8130_head.
- NP448884.RAOCoA1zHTAflEzGqGLbpgyhruY19Ztlm7YJ_ZPdbeiL8130_assertion description "[The United States CF Foundation recently proposed the term cystic fibrosis transmembrane conductance regulator related metabolic syndrome (CRMS) to describe infants with elevated immunoreactive trypsinogen (IRT) on NBS who do not meet diagnostic criteria for CF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP448884.RAOCoA1zHTAflEzGqGLbpgyhruY19Ztlm7YJ_ZPdbeiL8130_provenance.
- NP448884.RAOCoA1zHTAflEzGqGLbpgyhruY19Ztlm7YJ_ZPdbeiL8130_assertion evidence source_evidence_literature NP448884.RAOCoA1zHTAflEzGqGLbpgyhruY19Ztlm7YJ_ZPdbeiL8130_provenance.
- NP448884.RAOCoA1zHTAflEzGqGLbpgyhruY19Ztlm7YJ_ZPdbeiL8130_assertion SIO_000772 21538969 NP448884.RAOCoA1zHTAflEzGqGLbpgyhruY19Ztlm7YJ_ZPdbeiL8130_provenance.
- NP448884.RAOCoA1zHTAflEzGqGLbpgyhruY19Ztlm7YJ_ZPdbeiL8130_assertion wasDerivedFrom befree-20140225 NP448884.RAOCoA1zHTAflEzGqGLbpgyhruY19Ztlm7YJ_ZPdbeiL8130_provenance.
- NP448884.RAOCoA1zHTAflEzGqGLbpgyhruY19Ztlm7YJ_ZPdbeiL8130_assertion wasGeneratedBy ECO_0000203 NP448884.RAOCoA1zHTAflEzGqGLbpgyhruY19Ztlm7YJ_ZPdbeiL8130_provenance.